WallStreetZenWallStreetZen

NASDAQ: IVA
Inventiva Sa Stock Forecast, Predictions & Price Target

Analyst price target for IVA

Based on 3 analysts offering 12 month price targets for Inventiva Sa.
Min Forecast
$12.00+231.49%
Avg Forecast
$19.67+443.29%
Max Forecast
$25.00+590.61%

Should I buy or sell IVA stock?

Based on 3 analysts offering ratings for Inventiva Sa.
Strong Buy
Strong Buy
2 analysts 66.67%
Buy
1 analysts 33.33%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their IVA stock forecasts and price targets.

IVA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-20
lockedlocked$00.00+00.00%2024-02-16
lockedlocked$00.00+00.00%2023-10-27

1 of 1

Forecast return on equity

Is IVA forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
37.27%

Forecast return on assets

Is IVA forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

IVA revenue forecast

What is IVA's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$6.1M-74.92%
Avg 2 year Forecast
$6.0M-75.23%
Avg 3 year Forecast
$28.4M+17.36%
IVA's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

IVA revenue growth forecast

How is IVA forecast to perform vs Biotechnology companies and vs the US market?
Company
1.07%
Industry
39.22%
Market
10.52%
IVA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
IVA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

IVA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
IVA$3.62$19.67+443.29%Strong Buy
IMAB$1.86$8.00+330.11%Strong Buy
ARMP$4.18$7.00+67.46%Buy
OTLK$11.94$51.63+332.40%Strong Buy
ACHV$4.55$14.50+219.03%Strong Buy

Inventiva Sa Stock Forecast FAQ

Is Inventiva Sa Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: IVA) stock is to Strong Buy IVA stock.

Out of 3 analysts, 2 (66.67%) are recommending IVA as a Strong Buy, 1 (33.33%) are recommending IVA as a Buy, 0 (0%) are recommending IVA as a Hold, 0 (0%) are recommending IVA as a Sell, and 0 (0%) are recommending IVA as a Strong Sell.

If you're new to stock investing, here's how to buy Inventiva Sa stock.

What is IVA's revenue growth forecast for 2024-2026?

(NASDAQ: IVA) Inventiva Sa's forecast annual revenue growth rate of 1.07% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 39.22%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.52%.

Inventiva Sa's revenue in 2024 is $23,451,063.On average, 3 Wall Street analysts forecast IVA's revenue for 2024 to be $256,007,211, with the lowest IVA revenue forecast at $183,704,977, and the highest IVA revenue forecast at $331,595,910. On average, 1 Wall Street analysts forecast IVA's revenue for 2025 to be $252,805,014, with the lowest IVA revenue forecast at $252,805,014, and the highest IVA revenue forecast at $252,805,014.

In 2026, IVA is forecast to generate $1,197,874,425 in revenue, with the lowest revenue forecast at $1,197,874,425 and the highest revenue forecast at $1,197,874,425.

What is IVA's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: IVA) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is IVA's Price Target?

According to 3 Wall Street analysts that have issued a 1 year IVA price target, the average IVA price target is $19.67, with the highest IVA stock price forecast at $25.00 and the lowest IVA stock price forecast at $12.00.

On average, Wall Street analysts predict that Inventiva Sa's share price could reach $19.67 by Mar 20, 2025. The average Inventiva Sa stock price prediction forecasts a potential upside of 443.29% from the current IVA share price of $3.62.

What is IVA's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: IVA) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.